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ABSTRACTSCT remains the gold standard for the detection and follow-up of these
tumours.
Although diagnosis relies on morphology and immunohistochemistry, a
proportion of GISTs are cKit negative.
0727: IS GORD REDUCED AFTER NISSEN FUNDOPLICATION IN LUNG
TRANSPLANT PATIENTS?
Victoria Pegna 1, Frans Banki 2, Ceri Rowlands 1, Antanas Mickevicius 1,
Clement Tsang 1. 1 St Vincents, Sydney, Sydney, Australia; 2Maastricht
University, Maastricht, The Netherlands.
Aims: Assess whether LungFTs improve after Nissen-Fundoplication (NF)
in lung transplant patients and if this operation reduces the use of PPIs.
Methods: Retrospective case series of transplant patients with GORD and
NF 2004-2010. The FEV1 values before and after NF were collected at 3
monthly intervals. Post NF analysis of the use of PPI, acid exposure, length
of stay and safety of this procedure, and signiﬁcance of FEV1 post-op
values was carried out using SPSS.
Results: 64 selected. The mean FEV1 declined for 6 months post opera-
tively then gradually improved. However, the median value remained
steady after having the operation then trend towards an improvement. The
two tail t-test comparing themean at 3months preoperatively to 3months
post operatively showed no signiﬁcant difference at t¼ 0.067, and at 6
months was also not signiﬁcant. All patients remained on PPIs. No
mortalities.
Conclusion: Standardisation in management between physicians and
units around the world is needed. Patients remained on PPIs post NF but
pH studies reduced in acid exposure. There was improvement in FEV1 6
months post-operatively, but not signiﬁcant. Possibly because our number
of patients was too small, or beta error. A multicenter RCT is needed to
assess this topic further.
0731: THE METABOLIC OUTCOME OF GASTRIC BYPASS SURGERY: A SYS-
TEMATIC REVIEW
Jihene El Kafsi, Rebecca Howett, Ailsa Snaith. Oxford University Hospitals,
Oxford, UK.
Recent studies show over 80% diabetes remission one year post bariatric
surgery (Buchwald 2009).
This systematic review was conducted to evaluate the evidence for
changes in glucose homeostasis and gut hormone proﬁle following Roux-
En-Y Gastric Bypass.
MEDLINE (from 1952), EMBASE (from 1980) and the Cochrane Library
were searched. Studies that reported the metabolic outcomes of patients
undergoing Roux-En-Y gastric bypass surgery were reviewed. Only those
studies with more than 10 participants in the intervention group were
considered.
From 753 retrieved abstracts, 24 studies (527 participants) were included.
Following RYGB, metabolic outcomes were reported up to 3 years post
operatively: Fasting and peak glucose levels decreased in 13 out of 16
studies. Fasting insulin levels dropped signiﬁcantly in 12 out of 13 studies.
HOMA-IR decreased signiﬁcantly. PYY levels were signiﬁcantly increased
in 9 out of 11 studies and post-prandial GLP-1 levels were signiﬁcantly
raised following RYGB in all 21 studies measuring it.
Patients who underwent RYGB have improved glucose levels and insulin
sensitivity post-operatively, regardless of diagnosis of diabetes, impaired
glucose tolerance or normal glucose control. Current NICE guidelines do
not support the use of bariatric surgery for the treatment of impaired
glucose tolerance if the BMI does not exceed 35Kg/m2.
0965: HELICOBACTER PYLORI INFECTION AND TYPE 2 DIABETES MELLI-
TUS IN BARIATRIC PATIENTS e IS THERE A LINK?
Jason George, Nicholas Carter, Sean Manning, Mohamed Elkalaawy,
Majid Hashemi, Marco Adamo, Andrew Jenkinson. University College
Hospital, London, UK.
Background: Previous reports have suggested a causal relationship be-
tween Helicobacter Pylori (HP) and type 2 Diabetes Mellitus (T2DM).
Laparoscopic Sleeve Gastrectomy (LSG) involves resection of most of the
stomach and provides ample specimen to detect the presence of any HP
organisms. The aim of this studywas to assess the relationship between HP
and T2DM in bariatric patients who have undergone LSG.Method: All patients who have undergone LSG during the last ﬁve years
were identiﬁed from our prospectively collected database. Histology re-
sults were retrieved. Specimens were examined macroscopically and any
abnormalities sampled. Warthin-Starry staining was used to identify the
presence of any Helicobacter pylori organisms.
Results: 403 gastric specimens were examined and 224 (54%) had no
abnormalities. 333 cases (83%) had no HP present and of these 32% had
T2DM. 70 cases (17%) had HP present and of these, 19 (27%) were in pa-
tients with T2DM.15% of diabetics were positive for HP compared with 19%
of non diabetics being HP positive.
Conclusion: There were comparable numbers of diabetic patients in the
HP group and the non HP group. In bariatric patients undergoing sleeve
gastrectomy, no correlationwas identiﬁed between helicobacter pylori and
type 2 diabetes mellitus.
0990: TO AUDIT THE USE OF TEMPORARY GASTRIC ELECTRICAL STIMU-
LATION IN SELECTING PATIENTS WITH INTRACTABLE GASTROPARESIS
FOR TREATMENT WITH PERMANENT GASTRIC ELECTRICAL
STIMULATION
Martin Michel 1, Simon Dexter 1, Abeezer Sarela 1, Fahmid Chowdhury 2.
1Department of Upper GI Surgery, St. James's University Hospital, Leeds, UK;
2Department of Nuclear Medicine, St. James's University Hospital, Leeds, UK.
Aims: To audit the outcomes of patients treated with Gastric Electrical
Stimulation (GES) for Intractable Gastroparesis. The largest case-series
(N¼221) reports that 54% of patients had >50% symptom reduction with
permanent Gastric Electrical Stimulation.
Methods: Patients considered for GES during 2009-2012 were identiﬁed
from a gastroparesis database. Candidates for GES had a two-week trial of
temporary stimulation (TGES), via a trans-nasal electrode that was endo-
scopically implanted into the gastric submucosa. Only those with good
response proceeded to laparoscopic implantation of the GES device. 50% or
greater in symptom-reduction was classiﬁed as a good response.
Results: There were 72 patients (51 women 71%), with a median age 44
years. The aetiology of gastroparesis was Idiopathic (43 patients,60%),
Diabetic (15 patients, 21%) or Post-surgical (14, 19%). 58 patients (80%)
underwent TGES with 47 (81%) patients having a good response and
selected to have a permanent device, which has been completed in 45
patients. 32 patients (72%) had a good response to permanent GES; these
included 20 (71%) with idiopathic, 6 (66%) with post surgical and 6 out of 7
(85%) with diabetic gastroparesis.
Conclusions: 72% of well-selected patients with intractable gastroparesis
had good response to permanent gastric electrical stimulation at follow-up
to 3 years.
1011: POOLED DAY-CASE LAPAROSCOPIC CHOLECYSTECTOMY PER-
FORMED BY BOTH UPPER GI/HPB AND GENERAL SURGEONS: A SOLU-
TION TO THE GALLSTONE EPIDEMIC?
A. Stimpson, C. Mosli-Lynch, M. Sanders, M.J. Stechman. Cardiff and Vale
University Health Board, NHS Wales, UK, Cardiff, UK.
Background: Day-case laparoscopic cholecystectomy (LC) is the optimal
treatment for most patients with symptomatic gallstones but demand is
increasing rapidly. This study examines whether an optimal service can be
provided by a combination of 6 general surgeons and 3 GI surgeons sharing
the workload.
Methods: Retrospective study of consecutive patients undergoing LC at a
day surgery unit over 2011-2012. Conversions were recorded and com-
plications graded using the Clavien-Dindo (C-D) Classiﬁcation. Statistical
analysis was by c2 test.
Results: Over 2-years 463 patients (372F, median 45y, range 16-86) un-
derwent LC. Overall, 73% had day-case surgery and conversion rate was
2.6%. Non-GI surgeons performed 315 cases (2 conversions, 10.5% C-D
grade I/II) and GI surgeons performed 148 cases (8 conversions, 6.8% C-D
grade I/II). The complication rate requiring re-intervention (ERCP/re-lap-
aroscopy, C-D grade IIIa/b) was 4% in both groups. The difference in con-
version-rate reﬂected case-mix.
Conclusions: A collaborative approach between GI-specialists and General
surgeons may be a solution to the increasing demand for LC. It can be
performed safely by both with excellent day-case rates, and low risk of
conversion or signiﬁcant complications.
